Combined Molecular Microscopy for Therapy and Personalized Medication in Rare Anaemias Treatments
The aim of CoMMiTMenT is the development of combined imaging technologies based on optofluidic microscopy (OMiCS) and scanning ion conductance microscopy (SCIM), the so-called µCOSMOS, a multi-modular device, which will allow the exploration, diagnosis and development of therapeutic interventions for several rare anaemias. For some of the rare anaemias, CoMMiTMenT will provide an initial proof-of-principle, whereas for others, personalised medical interventions should become available and will be tested in clinical practice within the project. CoMMiTMenT will ensure an effective therapy with diminished undesirable adverse effects, largely replacing splenectomy, and will thus contribute to the goal of the International Rare Diseases Research Consortium (IRDiRC) to deliver novel diagnostic modalities and 200 new therapies for rare diseases by 2020.
- Dr Lars KästnerUniversität des Saarlandes (USAAR)Phone: +49 6841 1626149Email
- 60 months (October 2013 - September 2018)
- Project funding
- € 5,999,982.25
- Project partners